Chemotherapy Reduces Deaths in Early Breast Cancer

Chemotherapy used in early breast cancer as adjuvant treatment reduces deaths due to breast cancer by one third. The newer chemotherapy regimens appear to be more effective in this regard.

According to a recent study, the currently used chemotherapy regimens have reduced deaths due to breast cancer by approximately one-third compared to no chemotherapy.

A number of chemotherapy combinations have been used in the treatment of breast cancer. But is there any regimen that may be better than the rest? An analysis of more than 100 trials to compare the use of different types of chemotherapy in early breast cancer was carried out. The chemotherapy regimens studied were

Breast Cancer - Causes, Risks, Symptoms, Diagnosis, Staging, Treatment, Prevention & Prognosis
Breast cancer is a cancer that affects the breasts or mammary glands. Early detection and lifestyle changes help in controlling breast cancer.

• taxane-based versus non-taxane-based regimens

• anthracycline-based regimen versus standard or near-standard cyclophosphamide, methotrexate, and fluorouracil (CMF) regimen

• higher versus lower anthracycline dosage

Quiz on Breast Cancer
Breast cancer is one of the leading causes of cancer deaths among women. It is often said that a woman who breast-feeds is at a lower risk of developing cancer compared to another who does not .Are these mere old wives tales or is there some truth in it? This quiz on breast cancer has all the details.

• polychemotherapy versus no adjuvant chemotherapy

The analysis found the following:

Male Breast Cancer-Causes-Risk Factors-Signs-Symptoms-Diagnosis-Treatment-FAQs
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of male breast cancer often involves surgery.

• The older chemotherapy regimens reduced breast cancer deaths by about a quarter, the best being standard CMF and standard 4AC regimens. With these regimens, 2-year recurrence rates were halved and cancer recurrence rates during the next 8 years were reduced by one-third. Regimens using lower doses per cycle were less effective.

• Regimens with substantially more chemotherapy than standard 4AC were more effective. These included regimens such as CAF11, 15 or CEF19. These reduced deaths due to cancer by a further one-sixth.

Screening for Breast Cancer with Clinical Breast Examination
Clinical breast examination is a simple and inexpensive method of detecting breast cancer especially in women who do not have access to mammography.

• Chemotherapy reduced deaths due to cancer in all groups over a period of 10 years by about a third as compared to no chemotherapy. The reduction in deaths was irrespective of age, status of lymph nodes, tumor diameter, tumor differentiation or presence of estrogen receptors on the tumor.

• Deaths in ER-positive breast cancers are very much reduced when chemotherapy is combined with endocrine treatment rather than administration of endocrine treatment alone.

Chemotherapy may thus be beneficial in a number of women with early breast cancer as adjuvant treatment.

Reference:

1. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials; Breast cancer trials group; The Lancet, Volume 379, Issue 9814, Pages 432 – 444; Feb 2012.

Source-Medindia